Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties.
Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties. Cancer Immunol Immunother. 2010 Apr; 59(4):563-73.
-
Animals
-
Antibodies, Monoclonal
-
Antigens, Neoplasm
-
Blotting, Western
-
Breast
-
Breast Neoplasms
-
Cancer Vaccines
-
DEAD-box RNA Helicases
-
Enzyme-Linked Immunosorbent Assay
-
Epitopes, T-Lymphocyte
-
Female
-
Flow Cytometry
-
Histocompatibility Antigens Class I
-
Humans
-
Immunoenzyme Techniques
-
Mice
-
Mice, Nude
-
Molecular Mimicry
-
Peptide Fragments
-
Receptors, Antigen, T-Cell
-
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
-
Surface Plasmon Resonance
-
T-Lymphocytes, Cytotoxic